002275.SZ
桂林三金
SZSE · Healthcare · C 制造业 · CN
CNY 12.57
−4.99%Year over year
Reported trailing growth
- Revenue
- -3.4%
- EBITDA
- —
- EBIT
- -13.3%
- EPS
- -13.9%
- Free cash flow
- -14.1%
- Operating cash flow
- +9.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- +4.7%
- EBIT
- +6.5%
- Net income
- +9.5%
- EPS
- +9.7%
- Free cash flow
- +10.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026